0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Skin cancer diagnosis based on deep transfer learning and sparrow search algorithm

      ,
      Neural Computing and Applications
      Springer Science and Business Media LLC

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Skin cancer affects the lives of millions of people every year, as it is considered the most popular form of cancer. In the USA alone, approximately three and a half million people are diagnosed with skin cancer annually. The survival rate diminishes steeply as the skin cancer progresses. Despite this, it is an expensive and difficult procedure to discover this cancer type in the early stages. In this study, a threshold-based automatic approach for skin cancer detection, classification, and segmentation utilizing a meta-heuristic optimizer named sparrow search algorithm (SpaSA) is proposed. Five U-Net models (i.e., U-Net, U-Net++, Attention U-Net, V-net, and Swin U-Net) with different configurations are utilized to perform the segmentation process. Besides this, the meta-heuristic SpaSA optimizer is used to perform the optimization of the hyperparameters using eight pre-trained CNN models (i.e., VGG16, VGG19, MobileNet, MobileNetV2, MobileNetV3Large, MobileNetV3Small, NASNetMobile, and NASNetLarge). The dataset is gathered from five public sources in which two types of datasets are generated (i.e., 2-classes and 10-classes). For the segmentation, concerning the “skin cancer segmentation and classification” dataset, the best reported scores by U-Net++ with DenseNet201 as a backbone architecture are 0.104, \[94.16\%\] , \[91.39\%\] , \[99.03\%\] , \[96.08\%\] , \[96.41\%\] , \[77.19\%\] , \[75.47\%\] in terms of loss, accuracy, F1-score, AUC, IoU, dice, hinge, and squared hinge, respectively, while for the “PH2” dataset, the best reported scores by the Attention U-Net with DenseNet201 as backbone architecture are 0.137, \[94.75\%\] , \[92.65\%\] , \[92.56\%\] , \[92.74\%\] , \[96.20\%\] , \[86.30\%\] , \[92.65\%\] , \[69.28\%\] , and \[68.04\%\] in terms of loss, accuracy, F1-score, precision, sensitivity, specificity, IoU, dice, hinge, and squared hinge, respectively. For the “ISIC 2019 and 2020 Melanoma” dataset, the best reported overall accuracy from the applied CNN experiments is \[98.27\%\] by the MobileNet pre-trained model. Similarly, for the “Melanoma Classification (HAM10K)” dataset, the best reported overall accuracy from the applied CNN experiments is \[98.83\%\] by the MobileNet pre-trained model. For the “skin diseases image” dataset, the best reported overall accuracy from the applied CNN experiments is \[85.87\%\] by the MobileNetV2 pre-trained model. After computing the results, the suggested approach is compared with 13 related studies.

          Related collections

          Most cited references101

          • Record: found
          • Abstract: found
          • Article: not found

          Deep learning.

          Deep learning allows computational models that are composed of multiple processing layers to learn representations of data with multiple levels of abstraction. These methods have dramatically improved the state-of-the-art in speech recognition, visual object recognition, object detection and many other domains such as drug discovery and genomics. Deep learning discovers intricate structure in large data sets by using the backpropagation algorithm to indicate how a machine should change its internal parameters that are used to compute the representation in each layer from the representation in the previous layer. Deep convolutional nets have brought about breakthroughs in processing images, video, speech and audio, whereas recurrent nets have shone light on sequential data such as text and speech.
            Bookmark
            • Record: found
            • Abstract: not found
            • Conference Proceedings: not found

            Deep Residual Learning for Image Recognition

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cancer Statistics, 2021

              Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence. Incidence data (through 2017) were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data (through 2018) were collected by the National Center for Health Statistics. In 2021, 1,898,160 new cancer cases and 608,570 cancer deaths are projected to occur in the United States. After increasing for most of the 20th century, the cancer death rate has fallen continuously from its peak in 1991 through 2018, for a total decline of 31%, because of reductions in smoking and improvements in early detection and treatment. This translates to 3.2 million fewer cancer deaths than would have occurred if peak rates had persisted. Long-term declines in mortality for the 4 leading cancers have halted for prostate cancer and slowed for breast and colorectal cancers, but accelerated for lung cancer, which accounted for almost one-half of the total mortality decline from 2014 to 2018. The pace of the annual decline in lung cancer mortality doubled from 3.1% during 2009 through 2013 to 5.5% during 2014 through 2018 in men, from 1.8% to 4.4% in women, and from 2.4% to 5% overall. This trend coincides with steady declines in incidence (2.2%-2.3%) but rapid gains in survival specifically for nonsmall cell lung cancer (NSCLC). For example, NSCLC 2-year relative survival increased from 34% for persons diagnosed during 2009 through 2010 to 42% during 2015 through 2016, including absolute increases of 5% to 6% for every stage of diagnosis; survival for small cell lung cancer remained at 14% to 15%. Improved treatment accelerated progress against lung cancer and drove a record drop in overall cancer mortality, despite slowing momentum for other common cancers.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                Journal
                Neural Computing and Applications
                Neural Comput & Applic
                Springer Science and Business Media LLC
                0941-0643
                1433-3058
                January 2023
                September 23 2022
                January 2023
                : 35
                : 1
                : 815-853
                Article
                10.1007/s00521-022-07762-9
                693488aa-07d7-4fd0-824a-9262a4759764
                © 2023

                https://creativecommons.org/licenses/by/4.0

                https://creativecommons.org/licenses/by/4.0

                History

                Comments

                Comment on this article